Needle-free Drug Delivery Devices Market by Product and Geography - Forecast and Analysis 2020-2024

The global needle-free drug delivery devices market has the potential to grow by USD 10.23 billion during 2020-2024 and the market’s growth momentum will accelerate throughout the forecast period because of the steady increase in year-over-year growth.

This report provides a detailed analysis of the market by product (inhalers, transdermal patches, and jet injectors) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors including 3M Co., Antares Pharma Inc., Becton, Dickinson and Co., Enesi Pharma Ltd., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Mylan NV, Novartis AG, PharmaJet Inc., and Valeritas Holdings Inc.

Market Overview

Browse TOC and LoE with selected illustrations and example pages of needle-free drug delivery devices market

Request a FREE sample now!

Market Competitive Analysis

The needle-free drug delivery devices market is currently fragmented, and the degree of fragmentation will decrease during the forecast period. Market vendors are focusing on strategic alliances and launching new products to expand their geographical reach and strengthen their position in the needle-free drug delivery devices market. 3M Co., Antares Pharma Inc., and Becton are some of the major market participants. Although the growing prevalence of chronic diseases will offer immense growth opportunities, the high costs associated with needle-free drug delivery devices will challenge the growth of the market participants. To increase their needle-free drug delivery devices market share, companies should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market position, this needle-free drug delivery devices market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and provides information on the products offered by various companies. Moreover, this needle-free drug delivery devices market analysis report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading needle-free drug delivery device companies, including:

• 3M Co.
• Antares Pharma, Inc.
• Becton, Dickinson and Co.
• Enesi Pharma Ltd.
• GlaxoSmithKline Plc
• Inovio Pharmaceuticals Inc.
• Mylan NV
• Novartis AG
• PharmaJet Inc.
• Valeritas Holdings Inc.

Needle-free Drug Delivery Devices Market: Segmentation by Region